BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GREG FINLEY who wrote (192)	6/2/1998 12:06:00 PM
From: James Strauss	Read Replies (2) of 534

Being Gobbled Up... Here is a snipit from a recent news release... Said Mike Temple, chief financial officer of Bioject, ''As part of our strategic realignment, we have reduced our direct sales force and will focus on leveraging the sales and marketing capabilities of our corporate partners. Going forward, we anticipate this realignment will produce significant cost savings in the Company's needle-free business segment, as we continue to develop distribution alliances with Hoffmann-LaRoche and other potential partners.'' ********************************************************************** There are rumors that Hoffmann-LaRoche is a takeover candidate... This puts Bioject in the enviable position of two possible alliances for the price of one... Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next